Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2456 (LINC02456) is a member of the long intergenic non-coding RNA (lincRNA) subclass, which are RNA transcripts longer than 200 nucleotides that do not overlap with annotated protein-coding genes. LINC02456 is transcribed from a distinct intergenic region and, like other lincRNAs, is believed to regulate chromatin states, influence transcriptional control, stabilize other RNA transcripts, and potentially modulate gene expression in a tissue-specific manner. The specific biological functions, disease associations, and clinical relevance of LINC02456 are not currently well characterized. The lincRNA family overall is involved in epigenetic and regulatory processes throughout the genome, but only a minority of lincRNAs have been studied in detail. LINC02456 is not recognized as a therapeutic target nor are any drugs reported to interact with it.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2456 (LINC02456).